FdaApplication
NDA 208399
Identifiers
- fda_app_no: NDA208399
Properties
| Property | Value |
|---|---|
| applicant_name | TERSERA THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 2017-10-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VARUBI | ROLAPITANT HYDROCHLORIDE | EQ 166.5MG BASE/92.5ML (EQ 1.8MG BASE/ML) | EMULSION;INTRAVENOUS |
1 product